As part of an ongoing protocol involving the agnostic screening of patients with uncharacterized phenotypes for an upregulation of type I IFN signalling, we identified a patient (AGS460) with skin lesions and significant developmental delay to harbour a de novo c.295C>T/p.(R99C) substitution in ARF1 (Supplementary information). The gene discussed is ARF1; the disease is Global developmental delay.